Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL17224328 | 1.00 | GLRA1 (0.91) | — | |
| Glycine SCHEMBL142869 | 0.96 | — | — | |
| Glycine SCHEMBL28646078 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL29262734 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL15842974 | 0.96 | — | — | |
| Glycine SCHEMBL28179941 | 0.96 | — | — | |
| Glycine SCHEMBL28873025 | 0.96 | — | — | |
| Glycine SCHEMBL1627850 | 0.96 | — | — | |
| Glycine SCHEMBL2116443 | 0.95 | — | — | |
| Glycine SCHEMBL3640989 | 0.95 | GLRA1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3356 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074667-A | Nanometer oral liquid for sports nutrition, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260130927-A1 | PERMEABILITY ENHANCED ORAL THERAPY DELIVERY SYSTEM, AND METHOD OF MANUFACTURE | STELTING SCOTT ALAN (US) | 2026-05-14 | — | — | US | claimed |
| US-20260130850-A1 | TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF | LIFEACTIVE INC (US) | 2026-05-14 | — | — | US | claimed |
| CN-122005911-A | Hemostatic sponge with antibacterial and osteogenic properties, and preparation method and application thereof | 上海师范大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122010084-A | Compact porous carbon material and preparation method and application thereof | 溧阳天目先导电池材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260123649-A1 | COMPOSITIONS AND METHODS FOR NUTRACEUTICAL GUMMY | NOON WORLD INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4735008-A1 | IBOGAINE TREATMENT | Ambio Life Sciences Inc. (CA) | 2026-05-06 | — | — | EP | claimed |
| US-20260116895-A1 | CRYSTAL AND METHOD FOR PRODUCING THE SAME | SETOLAS HOLDINGS, INC. (JP) | 2026-04-30 | — | — | US | claimed |
| EP-0693280-A2 | Apparatus and process for strengthening low density compression dosage units and products therefrom | FUISZ TECHNOLOGIES LTD. (US) | 1996-01-24 | — | — | EP | claimed |
| EP-0578768-B1 | INGESTIBLE PHARMACEUTICAL COMPOSITIONS FOR TREATING UPPER GASTROINTESTINAL TRACT DISTRESS | PROCTER & GAMBLE (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0600725-A1 | Pharmaceutical compositions containing a guanidinothiazole and antacids | McNEIL-PPC, INC. (US) | 1994-06-08 | — | — | EP | claimed |
| EP-0578732-A1 | CHEWABLE ANTACID COMPOSITIONS. | PROCTER & GAMBLE (US) | 1994-01-19 | — | — | EP | claimed |
| EP-0578768-A1 | INGESTIBLE PHARMACEUTICAL COMPOSITIONS FOR TREATING UPPER GASTROINTESTINAL TRACT DISTRESS. | PROCTER & GAMBLE (US) | 1994-01-19 | — | — | EP | claimed |
| US-5244670-A | Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress | THE PROCTER & GAMBLE COMPANY (US) | 1993-09-14 | — | — | US | claimed |
| WO-1992017164-A1 | INGESTIBLE PHARMACEUTICAL COMPOSITIONS FOR TREATING UPPER GASTROINTESTINAL TRACT DISTRESS | THE PROCTER & GAMBLE COMPANY (US) | 1992-10-15 | — | — | WO | claimed |
| WO-1992017161-A1 | CHEWABLE ANTACID COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1992-10-15 | — | — | WO | claimed |
| US-4937076-A | CHOCOLATE OR HYDROGENATED TALLOW AS COATING AND BINDER; STORAGE STABILITY | COMBE INCORPORATED (US) | 1990-06-26 | — | — | US | claimed |
| US-4021536-A | Magnesium-zirconium complexes useful as antiperspirants | ARMOUR PHARMACEUTICAL COMPANY (US) | 1977-05-03 | — | — | US | claimed |